Biotech · Private company · Cambridge, MA, US
Brixton Biosciences, Inc.
Track this companyFree. Adds Brixton Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Neural IceOsteoarthritis (OA) of the KneeClinicalTrials.gov · fetched Nov 12, 2026
- ReneuRxGreater Trochanteric Pain SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Triamcinolone acetateGreater Trochanteric Pain SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Triamcinolone acetateOsteoarthritis (OA) of the KneeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip PainNA · RECRUITING · started Jul 27, 2026ClinicalTrials.gov NCT07568015 · fetched Nov 12, 2026
- INJECTABLE COLD ENERGY THERAPY FOR THE MANAGEMENT OF CHRONIC PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEENA · ACTIVE_NOT_RECRUITING · started Nov 19, 2024ClinicalTrials.gov NCT06700109 · fetched Nov 12, 2026
NIH awards2
- Neural Ice Technology for Treatment of PainFiscal year 2025 · $1MNIH RePORTER 5R44AR084998-02 · fetched Nov 12, 2026
- Neural Ice Technology for Treatment of PainFiscal year 2024 · $998.8KNIH RePORTER 1R44AR084998-01 · fetched Nov 12, 2026